United Therapeutics United States — Total long-lived assets increased by 40.5% to $1.74B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 40.5%, from $1.24B to $1.74B.
uthr_segment_united_states_total_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $768.10M | $871.10M | $1.06B | $1.24B | $1.74B |
| QoQ Change | — | +13.4% | +21.4% | +17.3% | +40.5% |
| YoY Change | — | +13.4% | +21.4% | +17.3% | +40.5% |